Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018; 14(5): 301–316. doi:10.1038/nrendo.2018.18

2. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008; 29(1): 76–131. doi:10.1210/er.2006-0043

Mehta SJ. Patient portals and mobile apps: opportunities to improve patient engagement. Am J Med. 2016; 129(9): e13–e14. doi: 10.1016/j.amjmed.2016.02.004

Young WF Jr. Diagnosis and management of primary aldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000– [updated 2018 Feb 8; cited 2024 Dec 6].

Scott JH, Menouar MA, Dunn RJ. Physiology, Aldosterone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [updated 2023 May 1]. PMID: 29261963.

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5): 1889–916. do